Skip to main content
Clinical Trials/NCT02849301
NCT02849301
Withdrawn
Phase 3

Cervical Pessary in Women With Arrested Preterm Labor and Short Cervix

Federico II University1 site in 1 countryJuly 2016
ConditionsPreterm Birth

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Preterm Birth
Sponsor
Federico II University
Locations
1
Primary Endpoint
Spontaneous preterm birth (SPTB)
Status
Withdrawn
Last Updated
7 years ago

Overview

Brief Summary

Preterm birth (PTB), defined as birth between 20 and 36 6/7 weeks, is responsible for the majority of the neonatal morbidity and mortality in the United States, and 35% of all U.S. healthcare spending on infants. Globally, about 28% of the 4 million annual neonatal deaths are directly attributable to PTB.

Preterm labor (PTL) is the final pathway for about 50% of all PTB. Tocolytic agents are drugs that can slow or stop labor contractions in the attempt to delay births preceded by PTL. Primary tocolysis is defined as tocolysis given on initial presentation of women with PTL. In most of these women, PTL stops, but as their risk of PTB remains high, some have advocated use of maintenance tocolysis, i.e. tocolysis after arrested PTL. So far, no maintenance tocolytic agent has been shown to be beneficial in preventing PTB.

The aim of this study is to evaluate the efficacy of maintenance tocolysis with Arabin pessary compared to standard care in singleton gestations with arrested PTL and with short transvaginal ultrasound (TVU) cervical length (CL) <25mm

Registry
clinicaltrials.gov
Start Date
July 2016
End Date
March 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Federico II University
Responsible Party
Principal Investigator
Principal Investigator

Gabriele Saccone

MD

Federico II University

Eligibility Criteria

Inclusion Criteria

  • 18-50 ages
  • Singleton pregnancy
  • 24(0) - 34(6) weeks of gestation
  • Arrested preterm labor after primary tocolysis
  • Transvaginal ultrasound cervical length less than 25mm at admission
  • Agreement to regular follow-up and provision of written informed consent

Exclusion Criteria

  • pessary and no cerclage in situ
  • vaginal bleeding
  • placeta previa/accreta
  • multiple gestations
  • \<24(0) or \>24(6) weeks of gestation
  • Cervical dilatation greater than 3 cm
  • Chorioamnionitis
  • Major fetal abnormalities
  • Abruptio placentae
  • Polyhydramnios or oligohydramnios

Outcomes

Primary Outcomes

Spontaneous preterm birth (SPTB)

Time Frame: Less than 34 weeks gestation

Secondary Outcomes

  • Admission to neonatal intensive care unit(Delivery (at birth))
  • Spontaneous preterm birth (SPTB)(Less than 37,35,32,28 and 24 weeks gestation)
  • Gestational age at delivery(Delivery (at birth))
  • intraventricular hemorrhage(Between birth and 28 days of age)
  • Latency(Delivery (at birth))
  • Birth weight(Delivery (at birth))
  • respiratory distress syndrome(Delivery (at birth))
  • low birth weight(Delivery (at birth))
  • neonatal mortality(Between birth and 28 days of age)

Study Sites (1)

Loading locations...

Similar Trials